Stocks are mixed Tuesday as investors tune into comments from Fed Chair Jerome Powell, speaking in Europe, and to see if U.S. equities will extend their bull run as the second half of 2025 gets underw ...

BCA Research, led by strategist Peter Berezin, is not celebrating the S&P 500’s recent wins. In fact, they are warning of ...

All large cryptocurrencies were down during U.S. morning trading on Tuesday, with Cardano Cardano USD seeing the biggest move ...

Mark Newton, head of technical strategy at Fundstrat, says Apple shares could be ready to finally shine and drive a bigger ...

President Donald Trump and Tesla CEO Elon Musk resumed their war of words, as the electric-vehicle maker’s stock slumped in ...

It’s not unusual for a business to put job seekers through a multi-step hiring process — including several interviews and ...

He’s not the first gold analyst to call the rally in gold over. A report from Citi in June prognosticated a 25% correction ...

Have an issue with your financial planner or looking for a new one? Email questions or concerns to [email protected].

Shares of Atai Life Sciences hit a two-year high after the company announced $50 million in private-placement financing and disclosed positive results for a study of a depression drug it has interests ...

I’m now writing to you for advice a second time. I’m 51, still married, 25 years now, and still residing in Maryland. My ...

Goldman Sachs now expects the Federal Reserve will make its next interest rate cut in September, and not December as ...

A portfolio manager pointed out a “unique” market development that could already be helping to tighten global crude ...